In breast and colorectal cancers, KLF4 has been shown to interact with other key transcription factors like Sox2 and Oct4 to regulate the balance between self-renewal and differentiation, thereby influencing tumor progression and response to therapy [28]. The gene discussed is SOX2; the disease is neoplasm.